- Home
- SLVM vs MNKD Comparison
SLVM vs MNKD Comparison
Compare SLVM & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLVM | MNKD |
|---|---|---|
| Founded | 1898 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Paper | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.7B |
| IPO Year | 2021 | 2004 |
Fundamental Metrics
Financial Performance| Metric | SLVM | MNKD |
|---|---|---|
| Price | $43.47 | $2.61 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $54.00 | $8.64 |
| AVG Volume (30 Days) | 335.9K | ★ 6.3M |
| Earning Date | 05-14-2026 | 05-29-2026 |
| Dividend Yield | ★ 4.12% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.24 | 0.02 |
| Revenue | ★ $3,351,000,000.00 | $348,966,000.00 |
| Revenue This Year | $0.98 | $33.40 |
| Revenue Next Year | $2.28 | $16.48 |
| P/E Ratio | ★ $13.48 | $130.75 |
| Revenue Growth | N/A | ★ 22.23 |
| 52 Week Low | $37.52 | $2.59 |
| 52 Week High | $68.76 | $6.51 |
Technical Indicators
Market Signals| Indicator | SLVM | MNKD |
|---|---|---|
| Relative Strength Index (RSI) | 35.38 | 17.12 |
| Support Level | $41.59 | N/A |
| Resistance Level | $43.81 | $6.08 |
| Average True Range (ATR) | 1.75 | 0.37 |
| MACD | -0.41 | -0.18 |
| Stochastic Oscillator | 27.99 | 2.62 |
Price Performance
Historical ComparisonAbout SLVM Sylvamo Corporation
Sylvamo Corp is an uncoated papers company with a broad portfolio of top-tier brands and low-cost, large-scale paper mills, it produces uncoated freesheet (UFS) for paper products such as cut size and offset paper, as well as market pulp. The company offers Copy and Printer papers, Commercial Printing papers, Converting papers and Specialty papers. It operates in three geographical segments: Europe, Latin America, and North America. Key revenue is generated from North America.
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.